What cannabis investors should watch for in 2026 after marijuana rescheduling
Cannabis investors may be feeling bullish entering 2026 after marijuana rescheduling, but some more advances are needed for growth.
President Trump Just Reclassified Marijuana. Are Green Thumb, Tilray, and Trulieve Stocks No-Brainer Buys?
Detailed price information for Tilray Brands Inc (TLRY-Q) from The Globe and Mail including charting and trades.
Everything Investors Need to Know About President Trump’s Executive Order Reclassifying Marijuana as a Lower Class of Drug
President Donald Trump just signed an executive order that reclassified marijuana from a Schedule I narcotic to Schedule III.
Cannabis use is up 46% among American seniors as Trump signs an order to reclassify marijuana. Are you positioned to profit if pot stocks surge?
This comes at a time when cannabis use among boomers is, well, booming. The number of Americans aged 65+ using cannabis for medical purposes rose from 4.8% in 2021 to 7% in 2023, a 46% jump in just …
Trump reschedules cannabis, leaving opening for hemp industry
On Thursday, President Trump signed an executive order, Increasing Medical Marijuana and Cannabidiol Research, that moves cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
The Cannabis Stock Big Money Managers Are Quietly Buying
These include Susquehanna International Group, which increased its position by around 2.75 million shares during Q3 2025. Other quantitative traders, including Citadel, Millennium Management, and D.E.
Cannabix Marijuana Breath Test Featured on the Cover of AlcoPro’s 2026 Product Catalog
Figure 1. Cannabix Technologies Inc. Marijuana Breath Test featured on cover of 2026 AlcoPro, Inc. product catalog Cannabix and AlcoPro have been working closely together on pre-launch marketing …
Want to buy some of the best marijuana stocks for 2026? Consider this ETF.
The cannabis sector is one that most investors would probably describe as a former bubble. But today, with valuations coming down significantly across the board and recent news that President Trump …
Trump’s ‘common sense’ overhaul of marijuana rules could boost budding industry. But investors should be on high alert
“The facts compel the federal government to recognize that marijuana can be legitimate in terms of medical applications when carefully administered,” Trump continued to reporters. “In some cases, this …
Marijuana stocks sell off as Trump signs executive order to reclassify cannabis
President Trump on Thursday signed an executive order asking the U.S. government to reschedule cannabis — a move that analysts and industry executives called the most significant federal reform on the …
Marijuana stocks tumble as Trump reclassifies drug but stops short of legalisation
US president’s order would categorise cannabis as less dangerous and remove it from grouping with heroin and LSD …
SA Quant ranks cannabis stocks as Trump signs rescheduling order
Cannabis stocks struggled on Thursday after President Donald Trump signed an executive order reclassifying marijuana as a less dangerous drug, signaling a shift in the U.S. cannabis market.
Cannabis stocks selling off as Trump signs rescheduling order
Cannabis stocks slid as Trump prepares to sign an executive order to reclassify marijuana as less dangerous. Read more here.
Trump signs executive order easing federal restrictions on marijuana
The executive order reclassifies marijuana as a Schedule III drug, easing the path for more research.
Recent Comments